Soutschek; Erwin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Soutschek; Erwin.The latest application filed is for "method for the immunological diagnosis of a sample with a potential infection with an arbovirus and test kits suitable for this ".

Company Profile

3.10.8

Soutschek; Erwin - Berg DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for the normalization of immunological tests and kits for performing such tests Grant 11,169,153 - Koch , et al. November 9, 2	2021-11-09
Method for the immunological diagnosis of a sample with a potential infection with an arbovirus and test kits suitable for this purpose Grant 10,921,323 - Soutschek , et al. February 16, 2	2021-02-16
Method For The Immunological Diagnosis Of A Sample With A Potential Infection With An Arbovirus And Test Kits Suitable For This App 20190227065 - SOUTSCHEK; Erwin ; et al.	2019-07-25
Method For The Normalization Of Immunological Tests And Kits For Performing Such Tests App 20190079091 - KOCH; Isabel ; et al.	2019-03-14
Immunological Test For The Detection Of E7 Oncoproteins In Biological Samples App 20180259523 - JANSEN-DURR; Pidder ; et al.	2018-09-13
Device for serologically detecting Yersinia infections and/or secondary diseases thereof and use of the proteins MyfA and PsaA of Y. enterocolitica and Y. pseudotuberculosis as recombinant antigens Grant 8,580,521 - Soutschek November 12, 2	2013-11-12
DEVICE FOR SEROLOGICALLY DETECTING YERSINIA INFECTIONS AND/OR SECONDARY DISEASES THEREOF AND USE OF THE PROTEINS MyfA AND PsaA OF Y. ENTEROCOLITICA AND Y. PSEUDOTUBERCULOSIS AS RECOMBINANT ANTIGENS App 20110306515 - Soutschek; Erwin	2011-12-15
Peptides derived from capsid antigens of the Epstein-Barr virus and the use thereof Grant 7,476,498 - Motz , et al. January 13, 2	2009-01-13
Method for determining early HCV seroconversion Grant 7,122,302 - Seidel , et al. October 17, 2	2006-10-17
Peptides derived from capsid antigens of the Epstein-Barr virus and the use thereof App 20060057563 - Motz; Manfred ; et al.	2006-03-16
Method for determining early HCV seroconversion App 20050095584 - Seidel, Christoph ; et al.	2005-05-05
Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines Grant 6,808,711 - Motz , et al. October 26, 2	2004-10-26
Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines App 20030185859 - Motz, Manfred ; et al.	2003-10-02
Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines Grant 6,610,301 - Motz , et al. August 26, 2	2003-08-26
Method for determining early HCV seroconversion App 20030129582 - Seidel, Christoph ; et al.	2003-07-10
Recombinant antigen from the NS3 region of the hepatitis C virus Grant 6,306,579 - Seidel , et al. October 23, 2	2001-10-23
Recombinant antigen from the NS3 region of the hepatitis C virus Grant 6,096,319 - Seidel , et al. August 1, 2	2000-08-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.